Evercore ISI Group Initiates Coverage On Electra Therapeutics with Outperform Rating, Announces Price Target of $36

10/13/2026
Impact: 70
Healthcare

Evercore ISI Group has initiated coverage on Electra Therapeutics (NASDAQ: ETRA) with an 'Outperform' rating. The firm has set a price target of $36 for the company's stock.

AI summary, not financial advice

Share: